| Targets of T cell responses to SARS-CoV-2 coronavirus in humans with COVID-19 disease and unexposed individuals A Grifoni, D Weiskopf, SI Ramirez, J Mateus, JM Dan, CR Moderbacher, ... Cell 181 (7), 1489-1501. e15, 2020 | 4152 | 2020 |
| Immunological memory to SARS-CoV-2 assessed for up to 8 months after infection JM Dan, J Mateus, Y Kato, KM Hastie, ED Yu, CE Faliti, A Grifoni, ... Science 371 (6529), eabf4063, 2021 | 3043 | 2021 |
| Antigen-specific adaptive immunity to SARS-CoV-2 in acute COVID-19 and associations with age and disease severity CR Moderbacher, SI Ramirez, JM Dan, A Grifoni, KM Hastie, D Weiskopf, ... Cell 183 (4), 996-1012. e19, 2020 | 1891 | 2020 |
| Detecting individual sites subject to episodic diversifying selection B Murrell, JO Wertheim, S Moola, T Weighill, K Scheffler, ... PLoS genetics 8 (7), e1002764, 2012 | 1672 | 2012 |
| Isolation of potent SARS-CoV-2 neutralizing antibodies and protection from disease in a small animal model TF Rogers, F Zhao, D Huang, N Beutler, A Burns, W He, O Limbo, C Smith, ... Science 369 (6506), 956-963, 2020 | 1398 | 2020 |
| Selective and cross-reactive SARS-CoV-2 T cell epitopes in unexposed humans J Mateus, A Grifoni, A Tarke, J Sidney, SI Ramirez, JM Dan, ZC Burger, ... Science 370 (6512), 89-94, 2020 | 1222 | 2020 |
| Development and use of personalized bacteriophage-based therapeutic cocktails to treat a patient with a disseminated resistant Acinetobacter baumannii infection RT Schooley, B Biswas, JJ Gill, A Hernandez-Morales, J Lancaster, ... Antimicrobial agents and chemotherapy 61 (10), 10.1128/aac. 00954-17, 2017 | 1193 | 2017 |
| Comparing physician and artificial intelligence chatbot responses to patient questions posted to a public social media forum JW Ayers, A Poliak, M Dredze, EC Leas, Z Zhu, JB Kelley, DJ Faix, ... JAMA internal medicine 183 (6), 589-596, 2023 | 1127 | 2023 |
| Antiretroviral Drugs for Treatment and Prevention of HIV Infection in Adults: 2016 Recommendations of the International Antiviral Society–USA Panel HF Günthard, MS Saag, CA Benson, C del Rio, JJ Eron, JE Gallant, ... JAMA 316 (2), 191-210, 2016 | 887 | 2016 |
| Antiretroviral drugs for treatment and prevention of HIV infection in adults: 2018 recommendations of the International Antiviral Society–USA Panel MS Saag, CA Benson, RT Gandhi, JF Hoy, RJ Landovitz, MJ Mugavero, ... JAMA 320 (4), 379-396, 2018 | 729 | 2018 |
| Impact of SARS-CoV-2 variants on the total CD4+ and CD8+ T cell reactivity in infected or vaccinated individuals A Tarke, J Sidney, N Methot, ED Yu, Y Zhang, JM Dan, B Goodwin, ... Cell Reports Medicine 2 (7), 2021 | 576 | 2021 |
| An altered intestinal mucosal microbiome in HIV-1 infection is associated with mucosal and systemic immune activation and endotoxemia SM Dillon, EJ Lee, CV Kotter, GL Austin, Z Dong, DK Hecht, S Gianella, ... Mucosal immunology 7 (4), 983-994, 2014 | 560 | 2014 |
| Gene-wide identification of episodic selection B Murrell, S Weaver, MD Smith, JO Wertheim, S Murrell, A Aylward, ... Molecular biology and evolution 32 (5), 1365-1371, 2015 | 546 | 2015 |
| Comprehensive analysis of T cell immunodominance and immunoprevalence of SARS-CoV-2 epitopes in COVID-19 cases A Tarke, J Sidney, CK Kidd, JM Dan, SI Ramirez, ED Yu, J Mateus, ... Cell Reports Medicine 2 (2), 2021 | 537 | 2021 |
| Antiretroviral Drugs for Treatment and Prevention of HIV Infection in Adults: 2020 Recommendations of the International Antiviral Society–USA Panel MS Saag, RT Gandhi, JF Hoy, RJ Landovitz, MA Thompson, PE Sax, ... Jama 324 (16), 1651-1669, 2020 | 503 | 2020 |
| Enhanced CD4+ T-cell recovery with earlier HIV-1 antiretroviral therapy T Le, EJ Wright, DM Smith, W He, G Catano, JF Okulicz, JA Young, ... New England Journal of Medicine 368 (3), 218-230, 2013 | 447 | 2013 |
| Neurocognitive change in the era of HIV combination antiretroviral therapy: the longitudinal CHARTER study RK Heaton, DR Franklin Jr, R Deutsch, S Letendre, RJ Ellis, K Casaletto, ... Clinical Infectious Diseases 60 (3), 473-480, 2015 | 439 | 2015 |
| Neutralizing antibody responses drive the evolution of human immunodeficiency virus type 1 envelope during recent HIV infection SD Frost, T Wrin, DM Smith Proc Natl Acad Sci USA 102 (51), 18514-9, 2005 | 430* | 2005 |
| Asymptomatic HIV-associated neurocognitive impairment increases risk for symptomatic decline I Grant, DR Franklin Jr, R Deutsch, SP Woods, F Vaida, RJ Ellis, ... Neurology 82 (23), 2055-2062, 2014 | 390 | 2014 |
| Sensitivity in detection of antibodies to nucleocapsid and spike proteins of severe acute respiratory syndrome coronavirus 2 in patients with coronavirus disease 2019 PD Burbelo, FX Riedo, C Morishima, S Rawlings, D Smith, S Das, ... The Journal of infectious diseases 222 (2), 206-213, 2020 | 368 | 2020 |
